The World Market for Flow Cytometry in IVD Applications: Forecasts to 2018

   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990

Published Jun 16, 2014 | 40 Pages | Pub ID: KLI5271977

The World Market for Flow Cytometry in IVD Applications

Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. Until recently flow cytometry has been used exclusively for these purposes. Other applications are seeing procedure growth.

This report, The World Market for Flow Cytometry in In Vitro Diagnostic Applications, is Kalorama's complete market analysis of this important diagnostics segment.

Market and Forecast 2013-2018 for Flow Cytometry in IVD
Breakout by Application (Cancer, HIV, Organ Transplant, Other)
Regional Breakout (US, EUR, ROW)
Country Markets for Flow Cytometry
Market Share by Company
Products on the Market
Key Company Profiles

Flow cytometry is useful in biotechnology, drug development, and clinical research. This report focuses only on IVD applications for flow. As part of its analysis, Kalorama considers growth drivers for the flow cytometry market in diagnostics, examines competitive moves by companies in the market, and reimbursment trends that will affect growth long-term. Profiled manufacturers include:

Beckman Coulter
Becton, Dickinson
EMD Millipore
Life Technologies
Luminex Corporation
Miltenyi Biotech
Partec Gmbh
Sony Biotechnology ( iCyt )
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.